Company Listing
Hydra Biosciences

Hydra is using its expertise in the Transient Receptor Potential (TRP) family of ion channels to discover novel drugs to treat pain, inflammation, cardiovascular conditions and other diseases. TRP channels offer numerous drug discovery opportunities in multiple areas of human disease. Hydra’s most advanced programme is in Phase I clinical trials. The company also has two ongoing collaborations with Boehringer Ingelheim.

BACK
Location
Cambridge, Massachusetts
CEO
Russell Herndon
Abingworth Partner
Vincent Miles
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Hydra is using its expertise in the Transient Receptor Potential (TRP) family of ion channels to discover novel drugs to treat pain, inflammation, cardiovascular conditions and other diseases. TRP channels offer numerous drug discovery opportunities in multiple areas of human disease. Hydra’s most advanced programme is in Phase I clinical trials. The company also has two ongoing collaborations with Boehringer Ingelheim.

Location
Cambridge, Massachusetts
CEO
Russell Herndon
Abingworth Partner
Vincent Miles
Website Address
BACK
 
Copyright Abingworth 2017